AIM ImmunoTech Files S-1 for Resale of 13.1M Shares

AIM ImmunoTech Inc. has filed an S-1 registration statement with the SEC for the resale of up to 13,077,089 shares of its common stock by selling stockholders. These shares originate from a registered direct offering and a concurrent private placement that concluded on June 10, 2026. The filing details the various components of the offering, including PIPE shares, shares underlying pre-funded warrants, Class J warrants, and placement agent warrants. The company's common stock is traded on the NYSE American under the ticker AIM, with the last reported price being $0.40 on June 17, 2026. AIM ImmunoTech will not receive proceeds from the resale of these shares, but could potentially receive up to $5.5 million if certain warrants are exercised for cash.